536 related articles for article (PubMed ID: 25253418)
1. Circulating glioma biomarkers.
Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
[TBL] [Abstract][Full Text] [Related]
2. Circulating Biomarkers for Glioma: A Review.
Jones J; Nguyen H; Drummond K; Morokoff A
Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
[TBL] [Abstract][Full Text] [Related]
3. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
4. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
Santangelo A; Imbrucè P; Gardenghi B; Belli L; Agushi R; Tamanini A; Munari S; Bossi AM; Scambi I; Benati D; Mariotti R; Di Gennaro G; Sbarbati A; Eccher A; Ricciardi GK; Ciceri EM; Sala F; Pinna G; Lippi G; Cabrini G; Dechecchi MC
J Neurooncol; 2018 Jan; 136(1):51-62. PubMed ID: 29076001
[TBL] [Abstract][Full Text] [Related]
5. DNA Associated with Circulating Exosomes as a Biomarker for Glioma.
Vaidya M; Sugaya K
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33137926
[TBL] [Abstract][Full Text] [Related]
6. Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers.
Díaz Méndez AB; Tremante E; Regazzo G; Brandner S; Rizzo MG
Neuropathol Appl Neurobiol; 2021 Jun; 47(4):471-487. PubMed ID: 33403678
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsies in patients with diffuse glioma.
Best MG; Sol N; Zijl S; Reijneveld JC; Wesseling P; Wurdinger T
Acta Neuropathol; 2015 Jun; 129(6):849-65. PubMed ID: 25720744
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
[TBL] [Abstract][Full Text] [Related]
9. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
10. Circulating microRNA biomarkers for glioma and predicting response to therapy.
Tumilson CA; Lea RW; Alder JE; Shaw L
Mol Neurobiol; 2014 Oct; 50(2):545-58. PubMed ID: 24696266
[TBL] [Abstract][Full Text] [Related]
11. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
Choppavarapu L; Kandi SM
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
[TBL] [Abstract][Full Text] [Related]
13. Blood-based biomarkers for the diagnosis and monitoring of gliomas.
Zachariah MA; Oliveira-Costa JP; Carter BS; Stott SL; Nahed BV
Neuro Oncol; 2018 Aug; 20(9):1155-1161. PubMed ID: 29746665
[TBL] [Abstract][Full Text] [Related]
14. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
[TBL] [Abstract][Full Text] [Related]
15. Circulating biomarkers for gliomas.
Westphal M; Lamszus K
Nat Rev Neurol; 2015 Oct; 11(10):556-66. PubMed ID: 26369507
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?
Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C
Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411
[TBL] [Abstract][Full Text] [Related]
18. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
19. Liquid biomarkers in glioma.
Tamai S; Ichinose T; Nakada M
Brain Tumor Pathol; 2023 Apr; 40(2):66-77. PubMed ID: 36800124
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNAs as potential noninvasive biomarkers for glioma.
Yu X; Li Z
Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
